arginyl-glycyl-aspartic acid has been researched along with curcumin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Kitamura, M; Konta, T; Lucio-Cazana, J; Moreno-Manzano, V; Nakayama, K | 1 |
Barui, S; Chaudhuri, A; Mondal, G; Saha, S | 1 |
Chu, L; Liu, J; Liu, Q; Song, N; Xu, H; Yang, C; Zhang, Y | 1 |
Guo, L; He, G; Huang, W; Li, X; Lin, D; Ouyang, L; Song, X; Wu, F; Zhao, Y | 1 |
Chang, R; Sun, L; Webster, TJ | 1 |
Dou, J; Lou, H; Xi, Y; Yang, C; Zhai, G; Zhao, L | 1 |
Akasov, R; Burov, S; Chiper, M; Dontenwill, M; Leko, M; Markvicheva, E; Vandamme, T; Zaytseva-Zotova, D | 1 |
Jiang, K; Shen, M; Xu, W | 1 |
Alipour, M; Ashraf Mirahmadi-Babaheidri, S; Bardania, H; Christiansen, G; Delaviz, H; Fouani, MH; Jafari Barmak, M; Mahmoudi, R | 1 |
Chen, JY; Jiang, JL; Ma, T; Qi, WX; Xu, HP | 1 |
10 other study(ies) available for arginyl-glycyl-aspartic acid and curcumin
Article | Year |
---|---|
Enhancement of TNF-alpha-induced apoptosis by immobilized arginine-glycine-aspartate: involvement of a tyrosine kinase-dependent, MAP kinase-independent mechanism.
Topics: Animals; Apoptosis; Benzoquinones; Cells, Cultured; Curcumin; Enzyme Inhibitors; Flavonoids; Genes, Dominant; Genistein; Glomerular Mesangium; Hydrogen Peroxide; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lactams, Macrocyclic; MAP Kinase Signaling System; Microscopy, Phase-Contrast; Mitogen-Activated Protein Kinases; Mutation; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Protein-Tyrosine Kinases; Pyridines; Quinones; Rats; Rifabutin; Time Factors; Transcription Factor AP-1; Transfection; Tumor Necrosis Factor-alpha | 2000 |
Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Curcumin; Drug Delivery Systems; Female; Human Umbilical Vein Endothelial Cells; Humans; Liposomes; Mice; Mice, Inbred C57BL; Neoplasms; Neovascularization, Pathologic; Oligopeptides | 2013 |
Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Curcumin; Diffusion; Hep G2 Cells; Humans; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanocapsules; Nanofibers; Neoplasms, Experimental; NIH 3T3 Cells; Oligopeptides; Protein Binding; Treatment Outcome | 2014 |
Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cholesterol; Curcumin; Drug Carriers; Drug Evaluation, Preclinical; Female; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Lipids; Melanoma; Mice; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Polyesters; Polyethylene Glycols; Polymers; Transplantation, Homologous | 2014 |
Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres.
Topics: Antineoplastic Agents; Arginine; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Microscopy, Electron, Transmission; Nanospheres; Oligopeptides; Osteoblasts; Osteosarcoma; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2015 |
Development of RGD-Functionalized PEG-PLA Micelles for Delivery of Curcumin.
Topics: Animals; Antineoplastic Agents; Cell Survival; Curcumin; Diffusion; Male; Mice; Micelles; Nanocapsules; Nanocomposites; Neoplasms, Experimental; Oligopeptides; Polyethylene Glycols; Treatment Outcome | 2015 |
Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Chemistry, Pharmaceutical; Curcumin; Dacarbazine; Doxorubicin; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Oligopeptides; Peptides, Cyclic; Spheroids, Cellular; Temozolomide | 2016 |
Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Curcumin; Drug Delivery Systems; Drug Liberation; Female; Humans; Liposomes; Lung Neoplasms; Male; Mice, Inbred BALB C; Oligopeptides; Paclitaxel; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2018 |
RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Curcumin; Drug Delivery Systems; Female; Humans; Liposomes; MCF-7 Cells; Microscopy, Electron, Transmission; Oligopeptides; Particle Size | 2021 |
A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.
Topics: Animals; Cell Line, Tumor; Curcumin; Deoxycytidine; Drug Carriers; Gemcitabine; Humans; Mice; Nanoparticles; Oligopeptides; Pancreatic Neoplasms; Particle Size; Serum Albumin, Human | 2022 |